CeresMED, a major medical cannabis and CBD seller in Vermont, has applied for an Act 250 permit to build a $6.6 million facility in Milton to grow, harvest and process cannabis, expanding its current operations.
The project in Catamount Industrial Park includes a greenhouse for starting young plants, which would be moved inside a 48,000-square-foot main building when they mature. In an Oct. 4 letter to the District 4 Commission for Act 250, an engineer consulting for the cannabis company said it intends to use alternative energy sources such as solar to "create a more environmentally sustainable operation."
The applicant for the Act 250 permit is High Fidelity Inc., the parent company for CeresMED, formerly Champlain Valley Dispensary.
"HFI has been in operation for over eight years and has an excellent record of compliance for not only worker safety but also maintaining patient privacy and security," wrote Engineer Andrew Rowe in the letter to the District 4 commission.
Read more at burlingtonfreepress.com
